The team treats you like a high-performance athlete. David M
Previous pharmacokinetic and longer-term phase III studies with subcutaneous semaglutide have indicated a similar safety profile to that of other GLP-1 receptor agonists [5,6,7,8, 15, 34]
Each provider is carefully vetted to ensure high-quality care and patient safety
Semaglutide in Grapevine/Southlake, TX Once-weekly injection Pre-filled pen injectors Inject under the skin (subcutaneous) Rotate injection sites (thigh, abdomen, upper arm) Tirzepatide in Grapevine/Southlake, TX Once-weekly injection Similar pen injector system Same injection method and sites Slightly different dosing schedule Many patients find the injection process easier than they expected
These findings align with literature proposing multiple pathways through which semaglutide may act, mitigating vascular stiffening, adverse lipid profiles, inflammation, and endothelial dysfunction, alongside effects on glycemic control, insulin resistance, and weight loss [1, 4]